Our CEO and founder Dr. Jonathan Vaught spoke at NCIA alongside Courtney Maltais of The Clear and moderator Rich Cardinal of the Next Big Crop about tissue culture in cannabis.
BOULDER, Colo., March 20, 2018 /PRNewswire/ — Front Range Biosciences (“FRB”) a leading agricultural biotech company that specializes in tissue culture propagation of high value crops, announced today that it has completed restoration
Thomas Mitchell of Westword published a piece on Jeff Sessions rescinding the Cole Memo and what that means for the cannabis industry, including hemp and medical marijuana. Dr. Vaught is featured
Issie Lapowsky of WIRED magazine wrote an article in reaction to the Cole Memo decision last week. Dr. Vaught is featured in the article. Still, those entrepreneurs who can are
Merry Jane did a full profile of FRB, interviewing Dr. Jonathan Vaught. Journalist Madison Margolin asked some great questions that show more of the details behind FRB’s process and philosophy.
FRB’s announcement about the partnership with UC Davis for cannabis genetics has received terrific coverage in the media! Below is a list of some of the top coverage. Newsweek, Weed
Our CEO, Dr. Jon Vaught, spoke at the Panel on Cultivation Trends as part of the Canopy Jump Start Conference. The focus of the conference was to help new startups
We are very proud to announce a partnership with the University of California, Davis to conduct research on the cannabis genome! Specifically, we are working on a new reference genome
Our CEO, Dr. Jon Vaught, gave a speech at the September 2017 gathering of the Nutrition Capital Network (NCN) during the Supply Side West Conference. Front Range Biosciences was the
Javier Hasse of Benzinga wrote a feature piece on Front Range Biosciences and our CEO, Dr. Jonathan Vaught. “Of course, scaling up brings benefits and challenges. As the size of